Advertising
We regulate advertisements for therapeutic goods. You need to know if that includes the product you intend to advertise.
Last updated
-
Advertising basics
Information about what is considered advertising, if advertising is allowed for your product and using the Advertising Code. -
Applying the Advertising Code
The Therapeutic Goods (Therapeutic Goods Advertising Code) Instrument 2021 (the Code) outlines requirements when advertising to the general public. -
Specialised advertising issues and topics
Explore advertising information on specific topics, such as social media and goods like Ozempic. Find out ways to promote health services offering products that cannot be advertised to the public. -
Understanding social media advertising rules
Find out how therapeutic goods legislation applies to social media posts, comments, hashtags, and paid promotions. Includes practical resources for businesses, influencers and consumers. -
Advertising legal framework
Information on the legal and regulatory framework underpinning our rules on advertising therapeutic goods. -
Advertising consultations
Find information on consultations and the Therapeutic Goods Advertising Consultative Committee (TGACC).
Compliance
-
Compliance and enforcement
We monitor and enforce compliance with laws that regulate health products. -
Advertising compliance and reports
How we manage advertising compliance, and where to find information about enforcement outcomes.
Latest alerts
-
TGA is issuing a safety advisory about the importation of unregistered GLP-1 products that are being promoted online for weight-loss.
-
Weleda Australia Pty Ltd is recalling one batch of Weleda Baby Teething Powder following a complaint that a fragment of glass was found in one bottle of this product.
-
We are aware of products being sold in Australia that claim to contain, or influence the levels of, nicotinamide adenine dinucleotide (NAD, NAD+, NADH) or nicotinamide mononucleotide (NMN) in the body.
Latest articles
-
Prime Medic Group issued infringement notices for alleged unlawful advertising of weight loss medicines
TGA has issued infringement notices to Prime Medic Group Pty Ltd (Prime Medic) and an individual for the alleged unlawful advertising of weight loss medicines in contravention of the Therapeutic Goods Act 1989 (the Act). -
TGA issues infringement notices to 6 individuals for alleged importation and unlawful advertising of therapeutic goods
We have issued 11 infringement notices totalling $43,560, to 6 individuals, for the alleged importation and unlawful advertising of therapeutic goods. -
TGA statement on sunscreen labelling practices
This statement provides guidance to industry about how the Therapeutic Goods Act 1989 applies in relation to sunscreen labelling.
Latest publications
-
Communique from the meeting of the TGACC
-
This plan outlines our compliance and education priorities for 2024-2025.
-
Communique from the meeting of the TGACC